These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36498820)

  • 1. Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities.
    Faccioli J; Nardelli S; Gioia S; Riggio O; Ridola L
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.
    Ridola L; Cardinale V; Riggio O
    Ann Gastroenterol; 2018; 31(2):151-164. PubMed ID: 29507462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with minimal hepatic encephalopathy.
    Ridola L; Nardelli S; Gioia S; Riggio O
    World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    World J Gastroenterol; 2019 Sep; 25(35):5257-5265. PubMed ID: 31558871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Encephalopathy: Diagnosis and Management.
    Ridola L; Faccioli J; Nardelli S; Gioia S; Riggio O
    J Transl Int Med; 2020 Dec; 8(4):210-219. PubMed ID: 33511048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
    World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy - recent advances in treatment and diagnosis.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal hepatic encephalopathy: A review.
    Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
    Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal hepatic encephalopathy.
    Stinton LM; Jayakumar S
    Can J Gastroenterol; 2013 Oct; 27(10):572-4. PubMed ID: 24106728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatic encephalopathy in the hospital.
    Leise MD; Poterucha JJ; Kamath PS; Kim WR
    Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy.
    Yoshimura E; Ichikawa T; Miyaaki H; Taura N; Miuma S; Shibata H; Honda T; Takeshima F; Nakao K
    Biomed Rep; 2016 Aug; 5(2):193-198. PubMed ID: 27446540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal hepatic encephalopathy.
    Dhiman RK; Chawla YK
    Indian J Gastroenterol; 2009; 28(1):5-16. PubMed ID: 19529896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of overt hepatic encephalopathy.
    Sharma P; Sharma BC
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis.
    Luo M; Yu XB; Hu SJ; Bai FH
    Saudi J Gastroenterol; 2020; 26(3):120-128. PubMed ID: 32270775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
    Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
    Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal hepatic encephalopathy matters in daily life.
    Bajaj JS
    World J Gastroenterol; 2008 Jun; 14(23):3609-15. PubMed ID: 18595126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.